Division of Cardiac Surgery, Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, CA.
Division of Cardiac Surgery, Cardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, CA.
Surgery. 2020 Oct;168(4):753-759. doi: 10.1016/j.surg.2020.04.055. Epub 2020 Jun 29.
Despite the introduction of several measures to reduce incidence, postoperative infections have been reported to increase. We aimed to assess trends in the incidence and impact of postoperative infections using a recent national cohort.
Patients undergoing the most commonly performed elective inpatient procedures in 9 surgical specialties were identified from the 2006 to 2014 National Inpatient Sample. Diagnostic coding was utilized to identify patients with postoperative infections. To adjust for patient and operative differences in assessing outcomes, an inverse probability of treatment weighing protocol was used.
Of an estimated 23,696,588 patients, 1,213,182 (5.1%) developed postoperative infections. Skin and soft tissue operations had the highest burden (12.9%) and endocrine the lowest (1.3%). During the study period, we found decreasing incidence, case fatality, and incremental cost of postoperative infections. Infection was associated with increased in-hospital mortality (1.4 vs 0.4%, P < .001), duration of stay (7.6 vs 3.7 days, P < .001), and costs ($27,597 vs $17,985, P < .001). Annually, postoperative infections led to an average incremental cost burden exceeding $700 million in the United States alone.
During the study period there was a substantial decrease in the burden of postoperative infections. Despite encouraging trends, postoperative infections continue to serve as a suitable quality improvement target, particularly in specialties with a high burden of infections.
尽管已经采取了多项措施来降低发病率,但术后感染的报道仍有所增加。我们旨在利用最近的全国队列评估发病率和术后感染的影响趋势。
从 2006 年至 2014 年全国住院患者样本中,确定了 9 个外科专业中最常进行的选择性住院手术的患者。使用诊断编码来识别术后感染的患者。为了调整评估结果中患者和手术的差异,使用了逆概率治疗加权协议。
在估计的 23696588 名患者中,有 1213182 名(5.1%)发生了术后感染。皮肤和软组织手术的负担最重(12.9%),内分泌手术的负担最低(1.3%)。在研究期间,我们发现术后感染的发病率、病死率和增量成本都有所下降。感染与住院死亡率增加(1.4%比 0.4%,P <.001)、住院时间延长(7.6 天比 3.7 天,P <.001)和费用增加($27597 比$17985,P <.001)有关。仅在美国,每年术后感染导致的增量成本负担平均超过 7 亿美元。
在研究期间,术后感染的负担大幅下降。尽管呈令人鼓舞的趋势,但术后感染仍然是一个合适的质量改进目标,特别是在感染负担较高的专业领域。